Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.

Drenberg CD, Saunders BO, Wilbanks GD, Chen R, Nicosia RF, Kruk PA, Nicosia SV.

Gynecol Oncol. 2010 Apr;117(1):117-24. doi: 10.1016/j.ygyno.2009.12.011. Epub 2010 Jan 13.

PMID:
20071014
[PubMed - indexed for MEDLINE]
2.

Urinary levels of Bcl-2 are elevated in ovarian cancer patients.

Anderson NS, Bermudez Y, Badgwell D, Chen R, Nicosia SV, Bast RC Jr, Kruk PA.

Gynecol Oncol. 2009 Jan;112(1):60-7. doi: 10.1016/j.ygyno.2008.09.037. Epub 2008 Nov 12.

PMID:
19007973
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):129-37.

PMID:
10067810
[PubMed - indexed for MEDLINE]
Free Article
4.

[Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].

Tan XJ, Lang JH, Shen K, Wang L, Wu M, Xu XY.

Zhonghua Fu Chan Ke Za Zhi. 2008 Jan;43(1):9-12. Chinese.

PMID:
18366924
[PubMed - indexed for MEDLINE]
5.

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1583.

PMID:
15734951
[PubMed - indexed for MEDLINE]
Free Article
6.

[Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].

Sun LX, Wu Y, Han HQ, Wang QH.

Ai Zheng. 2003 Jan;22(1):58-61. Chinese.

PMID:
12561438
[PubMed - indexed for MEDLINE]
7.

[The diagnostic and prognostic values of assay of serum vascular endothelial growth factor in epithelial ovarian cancer].

Tan X, Shen K, Liu D, Xu X, Lang J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Aug;22(4):352-5. Chinese.

PMID:
12903449
[PubMed - indexed for MEDLINE]
8.

Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.

Li L, Wang L, Zhang W, Tang B, Zhang J, Song H, Yao D, Tang Y, Chen X, Yang Z, Wang G, Li X, Zhao J, Ding H, Reed E, Li QQ.

Anticancer Res. 2004 May-Jun;24(3b):1973-9.

PMID:
15274387
[PubMed - indexed for MEDLINE]
Free Article
9.

Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.

Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY.

Gynecol Oncol. 1999 Aug;74(2):235-40.

PMID:
10419737
[PubMed - indexed for MEDLINE]
10.

Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.

Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kitano M, Kakishita E.

Br J Haematol. 2002 Mar;116(4):796-802.

PMID:
11886383
[PubMed - indexed for MEDLINE]
11.

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13.

PMID:
12582019
[PubMed - indexed for MEDLINE]
Free Article
12.

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.

Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.

Cancer. 1999 Jan 1;85(1):178-87.

PMID:
9921991
[PubMed - indexed for MEDLINE]
13.

Serum endostatin levels in patients with epithelial ovarian cancer.

Hata K, Dhar DK, Kanasaki H, Nakayama K, Fujiwaki R, Katabuchi H, Okamura H, Nagasue N, Miyazaki K.

Anticancer Res. 2003 Mar-Apr;23(2C):1907-12.

PMID:
12820477
[PubMed - indexed for MEDLINE]
14.

Early detection and prognosis of ovarian cancer using serum YKL-40.

Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, Sabbatini P, Anderson S, Aghajanian C, Holland EC, Spriggs DR.

J Clin Oncol. 2004 Aug 15;22(16):3330-9.

PMID:
15310777
[PubMed - indexed for MEDLINE]
Free Article
15.

Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.

Bozas G, Terpos E, Gika D, Karadimou A, Dimopoulos MA, Bamias A.

Int J Gynecol Cancer. 2010 Feb;20(2):248-54. doi: 10.1111/IGC.0b013e3181cc25c3.

PMID:
20134268
[PubMed - indexed for MEDLINE]
16.

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.

Havrilesky LJ, Whitehead CM, Rubatt JM, Cheek RL, Groelke J, He Q, Malinowski DP, Fischer TJ, Berchuck A.

Gynecol Oncol. 2008 Sep;110(3):374-82. doi: 10.1016/j.ygyno.2008.04.041. Epub 2008 Jun 27.

PMID:
18584856
[PubMed - indexed for MEDLINE]
17.

Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.

Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.

Gynecol Oncol. 2009 Mar;112(3):490-5. doi: 10.1016/j.ygyno.2008.11.006. Epub 2008 Dec 20.

PMID:
19101713
[PubMed - indexed for MEDLINE]
18.

The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.

Sköldenberg EG, Larsson A, Jakobson A, Hedborg F, Kogner P, Christofferson RH, Azarbayjani F.

Anticancer Res. 2009 Aug;29(8):3311-9.

PMID:
19661350
[PubMed - indexed for MEDLINE]
Free Article
19.

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.

Eur J Cancer. 2003 Sep;39(13):1948-56.

PMID:
12932675
[PubMed - indexed for MEDLINE]
20.

Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery.

Shantha Kumara HM, Tohme ST, Yan X, Nasar A, Senagore AJ, Kalady MF, Hyman N, Kim IY, Whelan RL.

Surg Endosc. 2011 Jun;25(6):1939-44. doi: 10.1007/s00464-010-1491-2. Epub 2010 Dec 22.

PMID:
21181203
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk